Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease.

Balakrishnan B, Azar J, Farha S, Goyanes AM, Lane JE, Paul D, Highland KB, Wang Y, Wang X, Tonelli AR

Open source

DOI
10.1016/j.rmed.2024.107835
Published
2024 Nov-Dec
Container
Respiratory medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rmed.2024.107835,
  title = {Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease.},
  author = {Balakrishnan B and Azar J and Farha S and Goyanes AM and Lane JE and Paul D and Highland KB and Wang Y and Wang X and Tonelli AR},
  year = {2024},
  journal = {Respiratory medicine},
  doi = {10.1016/j.rmed.2024.107835},
  url = {https://doi.org/10.1016/j.rmed.2024.107835}
}

RIS

TY  - JOUR
TI  - Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease.
AU  - Balakrishnan B
AU  - Azar J
AU  - Farha S
AU  - Goyanes AM
AU  - Lane JE
AU  - Paul D
AU  - Highland KB
AU  - Wang Y
AU  - Wang X
AU  - Tonelli AR
PY  - 2024
JO  - Respiratory medicine
DO  - 10.1016/j.rmed.2024.107835
UR  - https://doi.org/10.1016/j.rmed.2024.107835
ER  - 

APA

B, B., J, A., S, F., AM, G., JE, L., D, P., KB, H., Y, W., X, W., & AR, T. (2024). Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2024.107835

Source records